In the present study, we investigated the phenotype, functionality and TCR repertoire of peripheral blood and tumor-infiltrating γδ T cells in patients with late-stage melanoma receiving anti-PD-1 therapy, in order to further dissect their role and potential for exploitation in cancer immunotherapy. The gene discussed is PDCD1; the disease is cancer.